Expansion opportunities AMT is actively expanding its product line with new low-profile and specialty devices such as the MiniSPC Button, Explant Express, and AMT ONE Source app, signaling potential cross-sell opportunities to hospitals and surgical centers investing in newer enteral and urology solutions.

US manufacturing base All AMT products are designed, manufactured, and supported from the USA, highlighting reliability, domestic supply security, and potential messaging for U.S. procurement teams seeking onshore sourcing, shorter lead times, and enhanced compliance.

Clinical innovation AMT’s ongoing product innovations across enteral feeding, gastric and urinary devices, and suction removal technologies indicate appetite for high-value clinical solutions, presenting opportunities to position impact on patient outcomes and procedure efficiency.

Growing tech stack Investment in digital tooling such as the redesigned AMT ONE Source app and data-driven product configurations suggests potential for digital sales journeys, remote support, and streamlined purchasing processes for clinical buyers.

Mid-market focus With a workforce of 201-500 and revenue in the mid tens of millions, AMT represents a prime target for mid-market hospital networks and surgical groups seeking scalable, specialty device suppliers with strong quality assurance and US-based production.